Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43142

CCDC97 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

The CCDC97 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population in the HeLa human cervical adenocarcinoma cell line, targeting the CCDC97 gene. CCDC97 encodes a centriolar satellite protein that interacts with CEP290 and PCM1 and is critical for primary cilium formation and ciliary trafficking. Knockout of CCDC97 disrupts Hedgehog and Wnt signaling, affecting downstream effectors such as GLI1 and Cyclin D1. Applications include ciliogenesis assays by acetylated ??-tubulin immunofluorescence, Western blotting for pathway components, cell proliferation assays, and migration/invasion studies, supporting research in cancer cell biology and ciliopathies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    CCDC97

    Gene Identifier

    NCBI Gene ID 90324

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC97 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-mediated gene-disrupted polyclonal population in the HeLa human cervical adenocarcinoma cell line, targeting the CCDC97 locus. This polyclonal knockout model offers a heterogeneous cell population for loss-of-function studies without the biases of clonal isolation, ensuring that the functional consequences of CCDC97 disruption are assessed across a diverse genetic background. The product is designed for researchers investigating centrosome biology, ciliogenesis, and related signaling pathways.

HeLa cells are an immortalized epithelial cell line originally derived from a patient with cervical adenocarcinoma. These cells are a cornerstone of biomedical research, particularly in cancer biology, owing to their robust growth, extensive characterization, and aberrant centrosome amplification, which makes them an ideal host for studying centrosome-associated proteins like CCDC97.

CCDC97 encodes a coiled-coil domain-containing protein that localizes to centriolar satellites and is essential for primary cilium formation and ciliary trafficking. It interacts with components of the centriolar satellite machinery, including CEP290, PCM1, and OFD1, and associates with the BBSome complex. Upstream regulators include FOXJ1, RFX2, and RFX3 transcription factors, while downstream targets encompass GLI1, GLI2, and Cyclin D1. CCDC97 disruption impairs Hedgehog and Wnt signal transduction, leading to altered expression of IFT88 and ARL13B, and compromised ciliary function.

In the HeLa cell context, loss of CCDC97 disrupts primary cilium assembly and perturbs Hedgehog and Wnt signaling cascades that regulate proliferation, migration, and cell polarity. This model allows investigation of how ciliary defects influence cervical cancer cell behavior, including cell cycle progression, invasiveness, and drug sensitivity. The polyclonal nature captures population-level phenotypic heterogeneity, enhancing the translational relevance of the findings.

Key applications include immunofluorescence microscopy for acetylated ??-tubulin to assess ciliogenesis, Western blotting for Hedgehog pathway components such as GLI1 and SMO, cell proliferation assays, Transwell migration and invasion assays, and flow cytometric analysis of cell cycle distribution. The cells are also valuable for drug screening targeting centrosome or cilium pathways. For additional information or customized inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)